Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Armstrong

Showing results (711-720 of 1,035) with videos related to

Pageof 104
Sort By:
Cancer|January 22, 2009
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group studyKristin K Zorn, Chunqiao Tian, William P McGuire, et al.
Journal of Medical Screening|October 31, 1998
General practitioner screening for melanoma: sensitivity, specificity, and effect of trainingR C Burton, C Howe, L Adamson, et al.
Gynecologic Oncology|December 1, 2015
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group studyLisa M Landrum, William E Brady, Deborah K Armstrong, et al.
International Journal of Cancer|February 15, 1986
Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristicsD R English, P J Heenan, C D Holman, et al.
Journal of Hypertension|February 1, 2023
Sex-specific associations of reservoir-excess pressure parameters with age and subclinical vascular remodelingColin J Gimblet, Matthew K Armstrong, Virginia R Nuckols, et al.
International Journal of Cancer|February 10, 2007
Atopy, exposure to pesticides and risk of non-Hodgkin lymphomaClaire M Vajdic, Lin Fritschi, Andrew E Grulich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Assessment of lifetime cumulative sun exposure using a self-administered questionnaire: reliability of two approachesChu-Ling Yu, Yan Li, D Michal Freedman, et al.
Clinical and Experimental Rheumatology|June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic diseaseAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Gynecologic Oncology|November 25, 2011
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group studyChunqiao Tian, Christine B Ambrosone, Kathleen M Darcy, et al.
Gynecologic Oncology|January 21, 2012
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Chunqiao Tian, et al.
Pageof 104

Showing results (711-720 of 1,035) with videos related to

Sort By:
Pageof 104
Cancer|January 22, 2009
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group studyKristin K Zorn, Chunqiao Tian, William P McGuire, et al.
Journal of Medical Screening|October 31, 1998
General practitioner screening for melanoma: sensitivity, specificity, and effect of trainingR C Burton, C Howe, L Adamson, et al.
Gynecologic Oncology|December 1, 2015
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group studyLisa M Landrum, William E Brady, Deborah K Armstrong, et al.
International Journal of Cancer|February 15, 1986
Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristicsD R English, P J Heenan, C D Holman, et al.
Journal of Hypertension|February 1, 2023
Sex-specific associations of reservoir-excess pressure parameters with age and subclinical vascular remodelingColin J Gimblet, Matthew K Armstrong, Virginia R Nuckols, et al.
International Journal of Cancer|February 10, 2007
Atopy, exposure to pesticides and risk of non-Hodgkin lymphomaClaire M Vajdic, Lin Fritschi, Andrew E Grulich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Assessment of lifetime cumulative sun exposure using a self-administered questionnaire: reliability of two approachesChu-Ling Yu, Yan Li, D Michal Freedman, et al.
Clinical and Experimental Rheumatology|June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic diseaseAmi A Shah, Antony Rosen, Laura K Hummers, et al.
Gynecologic Oncology|November 25, 2011
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group studyChunqiao Tian, Christine B Ambrosone, Kathleen M Darcy, et al.
Gynecologic Oncology|January 21, 2012
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Chunqiao Tian, et al.
Pageof 104